| Net Loss per Share of Common Stock |
Note
4 – Net Loss per Share of Common Stock
Net
Loss Per Share
Basic
net loss per share is computed by dividing our net loss available to common stockholders by the weighted average number of shares of
common stock outstanding (which includes vested RSUs and unexercised pre-funded warrants) during the period. Diluted loss per share is
computed by dividing our net loss available to common stockholders by the diluted weighted average number of shares of common stock (which
includes the potentially dilutive effect of stock options, unvested RSUs and warrants) during the period. Since we experienced a net
loss for both periods presented, basic and diluted net loss per share are the same. As such, diluted loss per share for the three and
six months ended June 30, 2025 and 2024 excludes the impact of potentially dilutive common shares since those shares would have an anti-dilutive
effect on net loss per share.
The
computation of net loss per share for the three and six months ended June 30, 2025 and 2024 was as follows:
Schedule of Net Loss Per Share Basic and Diluted
| |
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
| |
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
| |
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
| Basic and diluted net loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss available to common stockholders |
|
$ |
(3,933,918 |
) |
|
$ |
(3,010,326 |
) |
|
$ |
(6,768,323 |
) |
|
$ |
(5,736,707 |
) |
| Weighted average number of common shares-basic and diluted |
|
|
15,569,312 |
|
|
|
2,983,283 |
|
|
|
12,401,583 |
|
|
|
2,724,903 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic and diluted net loss per share |
|
$ |
(0.25 |
) |
|
$ |
(1.01 |
) |
|
$ |
(0.55 |
) |
|
$ |
(2.11 |
) |
| |
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
| |
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
| Weighted-average number of common shares outstanding – basic and diluted |
|
|
15,545,266 |
|
|
|
2,849,192 |
|
|
|
12,371,909 |
|
|
|
2,590,530 |
|
| Weighted-average number of vested RSUs– basic and diluted |
|
|
24,046 |
|
|
|
134,091 |
|
|
|
29,674 |
|
|
|
134,373 |
|
| Weighted-average number of common shares-basic and diluted |
|
|
15,569,312 |
|
|
|
2,983,283 |
|
|
|
12,401,583 |
|
|
|
2,724,903 |
|
We
have excluded the following potentially dilutive securities from the calculation of diluted net loss per share since they would have
had an anti-dilutive effect:
Schedule of Dilutive Securities From The Calculation of Diluted Net Loss Per Share
| |
|
2025 |
|
|
2024 |
|
| |
|
June 30, |
|
| |
|
2025 |
|
|
2024 |
|
| Stock options |
|
|
2,747 |
|
|
|
2,747 |
|
| Restricted stock units (unvested) |
|
|
51,380 |
|
|
|
95,028 |
|
| Warrants for common stock |
|
|
30,495,784 |
|
|
|
1,778,284 |
|
| Total |
|
|
30,549,911 |
|
|
|
1,876,059 |
|
We
have not included any potential impact of the Series A and B Warrants from the January PO since they were subject to shareholder
approval as of June 30, 2025.
|